Literature DB >> 12092951

Prevalence of systolic hypertension in cats with chronic renal failure at initial evaluation.

Harriet M Syme1, Penney J Barber, Peter J Markwell, Jonathan Elliott.   

Abstract

OBJECTIVE: To determine prevalence of systolic hypertension and associated risk factors in cats with chronic renal failure evaluated in first-opinion practice.
DESIGN: Prospective study. ANIMALS: 103 cats with chronic renal failure. PROCEDURE: Systolic arterial blood pressure (SABP) was measured with a noninvasive Doppler technique, and cats that had SABP > 175 mm Hg on 2 occasions or that had SABP > 175 mm Hg and compatible ocular lesions were classified as hypertensive. Information from the history (previous treatment for hyperthyroidism, age), physical examination (sex, body weight), routine plasma biochemical analyses (creatinine, cholesterol, potassium, sodium, chloride, and calcium concentrations), and thyroid status were evaluated as potential risk factors for systolic hypertension. Variables associated with systolic hypertension were evaluated by use of logistic regression.
RESULTS: 20 (19.4%; 95% confidence interval, 13 to 28%) cats had systolic hypertension. Plasma potassium concentration was significantly and inversely associated with systolic hypertension. CONCLUSIONS AND CLINICAL RELEVANCE: Prevalence of systolic hypertension, although clinically important, was lower than that reported previously. The cause of the inverse association between systolic hypertension and plasma potassium concentration is not yet known.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12092951     DOI: 10.2460/javma.2002.220.1799

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  20 in total

Review 1.  Human heart failure with preserved ejection versus feline cardiomyopathy: what can we learn from both veterinary and human medicine?

Authors:  Valentine Prat; Bertrand Rozec; Chantal Gauthier; Benjamin Lauzier
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

2.  Randomized placebo-controlled clinical trial of a chewable formulation of amlodipine for the treatment of hypertension in client-owned cats.

Authors:  M Huhtinen; G Derré; H J Renoldi; M Rinkinen; K Adler; J Aspegrén; C Zemirline; J Elliott
Journal:  J Vet Intern Med       Date:  2015-04-09       Impact factor: 3.333

3.  Blood Pressure Measurements in 780 Apparently Healthy Cats.

Authors:  J R Payne; D C Brodbelt; V Luis Fuentes
Journal:  J Vet Intern Med       Date:  2016-12-01       Impact factor: 3.333

4.  Relationship between indirect blood pressure and various stages of chronic kidney disease in cats.

Authors:  Yasutomo Hori; Yasuhiro Heishima; Yohei Yamashita; Noriko Isayama; Nobuyuki Kanno; Kensuke Nakamura; Masayuki Iguchi; Toshiki Ibaragi; Hideyuki Onodera; Yoshitaka Aramaki; Atsushi Hirakawa; Shigeki Yamano; Michio Katagi; Akihito Kitade; Tamotsu Sawada
Journal:  J Vet Med Sci       Date:  2018-01-03       Impact factor: 1.267

5.  Factors Influencing the Relationship Between the Dose of Amlodipine Required for Blood Pressure Control and Change in Blood Pressure in Hypertensive Cats.

Authors:  E S Bijsmans; M Doig; R E Jepson; H M Syme; J Elliott; L Pelligand
Journal:  J Vet Intern Med       Date:  2016-09       Impact factor: 3.333

6.  Safety and efficacy of orally administered telmisartan for the treatment of systemic hypertension in cats: Results of a double-blind, placebo-controlled, randomized clinical trial.

Authors:  Amanda E Coleman; Scott A Brown; Anne M Traas; Lawrence Bryson; Tanja Zimmering; Alicia Zimmerman
Journal:  J Vet Intern Med       Date:  2019-03-09       Impact factor: 3.333

7.  Plasma renin activity and aldosterone concentrations in hypertensive cats with and without azotemia and in response to treatment with amlodipine besylate.

Authors:  R E Jepson; H M Syme; J Elliott
Journal:  J Vet Intern Med       Date:  2013-11-13       Impact factor: 3.333

8.  Changes in systolic blood pressure over time in healthy cats and cats with chronic kidney disease.

Authors:  E S Bijsmans; R E Jepson; Y M Chang; H M Syme; J Elliott
Journal:  J Vet Intern Med       Date:  2015-04-27       Impact factor: 3.333

9.  Effect on renal function of restoration of euthyroidism in hyperthyroid cats with iatrogenic hypothyroidism.

Authors:  T L Williams; J Elliott; H M Syme
Journal:  J Vet Intern Med       Date:  2014-04-28       Impact factor: 3.333

10.  ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats.

Authors:  Mark J Acierno; Scott Brown; Amanda E Coleman; Rosanne E Jepson; Mark Papich; Rebecca L Stepien; Harriet M Syme
Journal:  J Vet Intern Med       Date:  2018-10-24       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.